Bal Pharma Limited — Others, 04-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Bal Pharma Limited has confirmed compliance with SEBI regulations regarding the dematerialization and rematerialization of securities for the quarter ending March 31, 2025. The company verified and canceled any mutilated share certificates promptly, ensuring accurate records with the depositories.

This update underscores Bal Pharma's commitment to maintaining transparency and operational efficiency in managing shareholder equity. It may bolster investor confidence by reflecting effective governance practices. Overall, this development presents a positive outlook, reinforcing the company's dedication to shareholder interests.